| Iluvien (fluocinolone acetonide) / Alimera Sci, EyePoint Pharma |
NCT02472366: A Non-Randomized, Open-Label, Single Center Phase 4 Study of the Effect and Safety of ILUVIEN® in Chronic Diabetic Macular Edema Patients Considered Insufficiently Responsive to Available Therapies (Laser, Anti-VEGF) With or Without Intravitreal Corticosteroid Therapy |
|
|
| Completed | 4 | 16 | Europe | ILUVIEN | Alimera Sciences | Chronic Diabetic Macular Edema | 03/15 | 05/15 | | |
| Completed | 4 | 12 | Europe | IlUVIEN, Fluocinolone Acetonide | Association for Innovation and Biomedical Research on Light and Image | Diabetic Macular Edema | 03/16 | 12/16 | | |
FAD, NCT02902744: Fluocinolone Acetonide Insert (ILUVIEN®) for Diabetic Macular Edema () Study |
|
|
| Withdrawn | 4 | 0 | US | ILUVIEN®, Fluocinolone Acetonide Intravitreal Implant 0.19 mg | Johns Hopkins University | Diabetic Macular Edema | 08/17 | 08/17 | | |
2016-004488-38: Investigation of the influence of the corticosteroid agent Iluvien on inflammation and growth factors in the eye of patients suffering from diabetic-related retina damage with swelling of the centre of the retina Untersuchung des Einflusses des Kortikosteroid-Medikamentes Iluvien auf die Entzündungs- und Wachstumsfaktoren im Auge von Patienten, die untereiner Diabetes-bedingten Netzhautschädigung mit Schwellung der Netzhautmitte leiden |
|
|
| Ongoing | 4 | 12 | Europe | Intravitreal implant in applicator, ILUVIEN 190 Mikrogramm intravitreales Implantat im Applikator | J. W. Goethe University, represented by dean of the medical faculty, Alimera Sciences Ophthalmologie GmbH | Diabetic related Macula edema Diabetisches Makulaödem, Diabetic-related retina damage with swelling of retina centre Diabetes-bedingte Netzhautschädigung mit Schwellung der Netzhautmitte, Diseases [C] - Eye Diseases [C11] | | | | |
| Completed | 4 | 153 | US | ILUVIEN 0.19 MG, Fluocinolone Acetonide Intravitreal Implant 0.19 mg | Alimera Sciences | Diabetic Macular Edema (DME) | 07/20 | 07/20 | | |
NCT04469595: A Study of Intravitreal ILUVIEN® Implant as Baseline Therapy in Patients With Early Diabetic Macular Edema (DME) |
|
|
| Active, not recruiting | 4 | 300 | US | Iluvien 0.19 MG Drug Implant, ILUVIEN, Aflibercept, Eylea | Alimera Sciences | Diabetic Macular Edema | 12/24 | 12/24 | | |
